Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 60 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DR. PIET OST, RADIOTHERAPIE from Gent, company number BE0761430796, closed financial year 2025 with a result of € 344,131 after tax. For that financial year DR. PIET OST, RADIOTHERAPIE recorded a gross margin of € 458,692 and equity of € 4,000. Compared with financial year 2024, the result moved from € 340,771 to € 344,131. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 23, 2025.
€ 4,000
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 344,131
▲ 1% vs 2024
Profit after tax over the fiscal year.
€ 213,157
▼ 26% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 344,131 paid out
100 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 3,173
▼ 54% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 492
▲ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 56,517
▼ 34% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 255,964 | € 246,750 | € 455,392 | € 458,692 | ▲ 1% |
| Profit after taxes | € 192,475 | € 185,577 | € 340,771 | € 344,131 | ▲ 1% |
| Equity | € 357,104 | € 542,681 | € 4,000 | € 4,000 | |
| Total debts | € 69,850 | € 67,447 | € 438,756 | € 355,616 | ▼ 19% |
| Cash | € 249,632 | € 472,415 | € 289,174 | € 213,157 | ▼ 26% |
| Retained profit | € 353,104 | € 538,681 | € 0 | € 0 | |
| Dividend | € 0 | € 0 | € 879,452 | € 344,131 | ▼ 61% |
| Balance sheet total | € 426,955 | € 610,128 | € 442,756 | € 359,616 | ▼ 19% |
Key figures of DR. PIET OST, RADIOTHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to DR. PIET OST, RADIOTHERAPIE?
What happened at DR. PIET OST, RADIOTHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 344,131 (▲ 1% vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Piet Ost became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 192,475 profit in 2022 to € 344,131 profit in 2025.
Paid € 333,915 in corporate taxes since 2022.
Best year ever: 2025, with € 344,131 profit.
Paid out € 1.2 million in dividends to the owners in total.
Management
Behind DR. PIET OST, RADIOTHERAPIE is Piet Ost. Piet Ost is also behind EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY.
Directors
According to the 2025 annual accounts
since 2021
Establishments
Establishment units
Physical locations of this company
Beekstraat 35
9031 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0761.430.796
- VAT number
- BE 0761.430.796
- Registered office
- Beekstraat 35, 9031 Gent
- Names & denominations
- DR. PIET OST, RADIOTHERAPIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 11 January 2021
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van medisch specialisten